Back to Top Skip to main content Skip to sub-navigation

“Shots in arms” – OPT planned & coordinated to meet COVID-19 mission

Image of Military personnel sitting around a table talking. Members of the Department of Defense’s COVID-19 Operational Planning Team meet at Defense Health Agency Headquarters in Falls Church, Virginia, May 18 (Photo by: Mark Oswell, MHS Communication).

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus & the MHS Response

On May 24, the Department of Defense’s COVID-19 Operational Planning Team (OPT) transitioned its mission to the Coronavirus Vaccine Immunization Program (CVIP) working group.

The OPT was established last November by the Secretary of Defense and given the authority to oversee the Department of Defense's COVID-19 vaccination operations.

Under the direction of Defense Health Agency Director, Army Lt. Gen (Dr.) Ronald Place; and leadership of Army Maj. Gen. (Dr.) George "Ned" Appenzeller, DHA’s assistant director for combat support, the OPT brought together a diverse team of nearly 85 representatives from across the DOD to develop and execute the complex plan to safely and efficiently administer COVID-19 vaccines to the DOD's globally dispersed population.

The team consisted of representatives from the DHA, service branches, National Guard Bureau, Coast Guard, Joint Staff Surgeon’s Office, combatant commands, Defense Logistics Agency, and U.S. Army Medical Materiel Agency - Distribution Operations Center, and worked closely with the Countermeasures Acceleration Group (previously known as Operation Warp Speed), the DOD COVID-19 Task Force, the Department of Health And Human Services, and the Centers for Disease Control and Prevention.

The OPT focused on four priorities:

  • Protect service members
  • Protect DOD civilians and their families
  • Safeguard national security capabilities
  • Support a whole-of-nation response to the COVID-19 pandemic

From those orders, the team went to work; spending long days, nights, and weekends to formulate the COVID-19 vaccination plan for the DOD. This plan eventually grew to 512 pages consisting of 15 modifications and over 30 appendices.

"Once we got those priorities, the DOD basically said, "The OPT is responsible to support the whole-of-nation response to receive, distribute and administer COVID-19 vaccines,'" explained Air Force Col. Jennifer Garrison, OPT team leader.

Military personnel posing for a picture
Members of the Department of Defense’s COVID-19 Operational Planning Team pose with Defense Health Agency Director Army Lt. Gen. (Dr.) Ronald J. Place (fourth from right), and Maj. Gen. (Dr.) George “Ned” Appenzeller, DHA Combat Support assistant director (far left) at Defense Health Agency Headquarters in Falls Church, Virginia, May 18 (Photo by: Mark Oswell, MHS Communication)

Under Garrison's leadership, the OPT set-up 10 working groups, including the Services and Combatant Commands Synchronization Working Group, Vaccine Board, Allocations and Apportionment Board, Information Technology Working Group, Logistics Working Group, Joint Planning Group, Transition Working Group and others to execute this complex operational mission for the Secretary of Defense. The OPT also provided daily vaccine operations briefs to the COVID Task Force, DOD leadership, services, the Joint Staff and Combatant Commands to ensure smooth operations and strategic communications for successful mission accomplishment to all DOD eligible personnel.

Through the working groups, the OPT developed a multi-phased approach that began with planning and then transitioned to a pilot phase when vaccines became available under Emergency Use Authorization in early December.

"After planning, we went through a pilot phase, where we tested our ability to distribute the vaccines to 16 pilot sites, 12 inside the United States and four overseas," explained Garrison. "In conjunction with DOD leadership, the Joint Staff, Health Affairs, HHS and the CDC, we also conducted a vaccine distribution table top exercise to prove our concept for vaccine distribution and discover gaps within the plan. After the pilot and exercise, we were very confident in our ability to safely provide vaccines to our worldwide population."

The "expanded distribution" phase which lasted from January to May, began after the first 16 DOD vaccination pilot sites had been issued vaccine, and distribution, storage, administration, and reporting processes were validated. During this phase the OPT developed a process to equally and proportionally allocate the limited supply of vaccine to all the DOD populations, first by using a pro-rata based upon numbers of service members in the DOD population tiers, and later, pro-rata by the number of DOD eligible persons in geographic locations surrounding the DOD vaccination sites. In May 2021, as the amount of vaccine increased, the plan transitioned to the "saturation" phase.

"In this phase, DHA gave the responsibility over to the military services to place their vaccine orders based upon their demand," Garrison said.

The "saturation" phase closely resembled standard vaccine procedures in terms of requisition, distribution and allocation.

Air Force Col. (Dr.) Tonya Rans, medical lead for the OPT and team lead for the CVIP working group, explained how a vaccination ultimately results in a stronger, more medically ready force.

"Although the preventative practices the DOD instituted – masks, physical distancing, etc. – worked very well in keeping our population safe, its benefits stopped if there were lapses in practice. Offering an FDA-authorized COVID-19 vaccine, where initial and ongoing studies continue to demonstrate its safety and efficacy, provides longer protection," Rans said. "Those that have been vaccinated can now feel more comfortable that they will remain healthy from the COVID-19 disease while in environments where it is difficult to maintain other preventative measures."

Garrison expounded upon how proud she was with what the OPT was able to accomplish: "Aside from accomplishing the secretary of defense's priorities, they were also able to deliver the required amount of the vaccine to the various combatant commands, and as support the Military Health System in administering vaccines to the 12- to 17-year-old age group, she added.

The transition from the OPT to the CVIP working group signifies the successful development and implementation of the DOD's vaccination plan, but not the completion of the mission. Garrison explained how the mission of the OPT, and now the CVIP working group, always was and continues to be to get, "shots in arms as safely and quickly as possible."

She also articulated how none of this would have been possible without an inter-service effort and the personnel in the field. "We couldn't have done this without the Joint Staff, the services and the combatant commands supporting us in ensuring that all eligible DOD populations were getting the vaccine as fast as we could get it to them," said Garrison.

"The success of the DOD COVID-19 Vaccine Distribution Operation led by Lt. Gen. Place truly shows the value of the Defense Health Agency in its role as an operational combat support agency," concluded Garrison. "This endeavor highlights DHA's ability to bring together a successful and effective team and work with the services to support the needs of the Combatant Commands, and other DOD agencies and field activities."

You also may be interested in...

COVID-19: Bivalent Boosters

Infographic
9/19/2022
COVID-19: Bivalent Boosters

COVID-19 Bivalent Booster are now available!

Recommended Content:

Coronavirus and the COVID-19 Vaccine

COVID-19: Bivalent Booster, Did you know?

Infographic
9/19/2022
COVID-19: Bivalent Booster, Did you know?

Updated COVID-19 Boosters available!

Recommended Content:

Coronavirus and the COVID-19 Vaccine

COVID-19: Bottom Line on Boosters

Infographic
9/19/2022
COVID-19: Bottom Line on Boosters

Bottom Line on Boosters: Stay up to date!

Recommended Content:

Coronavirus and the COVID-19 Vaccine

COVID-19: Bivalent Booster, New

Infographic
9/19/2022
COVID-19: Bivalent Booster, New

New Booster for Fall!

Recommended Content:

Coronavirus and the COVID-19 Vaccine

COVID-19: Bivalent Booster, Get Boosted

Infographic
9/19/2022
COVID-19: Bivalent Booster, Get Boosted

Get Boosted!

Recommended Content:

Coronavirus and the COVID-19 Vaccine

DHA Form 207: COVID-19 Vaccine Screening and Immunization Document v22

Form/Template
9/9/2022

The purpose of this form is to determine if the COVID-19 vaccine can be administered to the patient. (v22, Sept. 2022)

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Immunization Healthcare Division | COVID-19 Vaccine Efforts | COVID-19 Information for Military Treatment Facility Directors | Coronavirus

Novavax COVID-19 Vaccine Now Available for 12 to 17 Year-Olds

Article
8/30/2022
Air Force Staff. Sgt. fills a syringe with a COVID-19 vaccine at Ramstein Air Base, Germany.

Novavax COVID-19 Vaccine is Available for Those 12 Years' Old and Above

Recommended Content:

Coronavirus and the COVID-19 Vaccine | COVID-19 Vaccine Efforts

New COVID-19 Boosters Against Subvariants Coming Soon

Article
8/29/2022
Marine on right gets a COVID-19 booster vaccination from a nursing student on his left.

Brooklyn Marine gets COVID-19 booster vaccination.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | COVID-19 Vaccine Efforts

How to Get Your Kids Up to Date on Vaccinations

Article
8/25/2022
Child wearing a mask getting the COVID-19 vaccine

Resources to help you get and keep your child’s immunizations up to date in time for back to school.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Back to School Immunizations | Immunization Healthcare Division

COVID-19 Vaccines

Infographic
8/18/2022
COVID-19 Vaccines

How COVID-19 Vaccines Work – There are three types of vaccines currently available: mRNA, subunit protein, and viral vector. Pfizer and Moderna are mRNA vaccine. Novavax is a subunit protein vaccine. Janssen is a viral vector vaccine. All products resemble a virus for the immune system to fight.

Recommended Content:

Coronavirus and the COVID-19 Vaccine

COVID-19 Novavax Vaccine

Infographic
8/18/2022
COVID-19 Novavax Vaccine

The Novavax COVID-19 Vaccine, Adjuvanated includes two doses, 21 days apart. Remember to mark your calendar and schedule time for your second dose.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Types of COVID-19 Vaccines

Consolidated Department of Defense Coronavirus Disease 2019 Force Health Protection Guidance

Policy

Consolidates and updates the Department’s guidance regarding vaccination verification, vaccination status, COVID-19 testing, surveillance and screening testing, personnel protection on-site mask requirements, (e.g., DHA military medical treatment facilities, meetings, travel), and the protection of personally identifiable information.

COVID-19 Moderna Vaccine

Publication
8/17/2022

Moderna and mRNA vaccines are available. Moderna includes two doses, 28 days apart.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | Types of COVID-19 Vaccines | Coronavirus & the MHS Response

COVID-19 Pfizer Vaccine

Publication
8/17/2022

Pfizer mRNA vaccines are available. Pfizer includes two doses, 21 days apart.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | Types of COVID-19 Vaccines | Coronavirus & the MHS Response

COVID-19 Moderna and Pfizer Vaccines

Publication
8/17/2022

Moderna and Pfizer mRNA vaccines are available. Moderna includes two doses, 28 days apart. Pfizer includes two doses, 21 days apart. Remember to mark your calendar and schedule time for your second dose

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | Types of COVID-19 Vaccines | Coronavirus & the MHS Response
<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 33
Refine your search
Last Updated: May 28, 2021

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.